FDA panel rejects OTC cholesterol drug
230314
Government advisers on Thursday rejected Merck & Co.'s bid for over-the-counter sales of Mevacor, the granddaddy of the famed cholesterol-lowering drugs.
119824
A US federal judge refused to allow a class-action lawsuit to proceed against Merck for health problems linked to its Vioxx pain medication, in a major victory for the pharmaceutical giant.
681063
U.S. patent officials have initially rejected claims for the basic patent on Pfizer Inc's blockbuster Lipitor cholesterol treatment, although the drug maker said on Monday it remained confident the patent would ultimately be upheld.
115250
A high-dose regimen of Merck&#39;s cholesterol drug Zocor offered no conclusive benefits over a low-cholesterol diet and a lower dose of Zocor in preventing a recurrence of cardiac events
707710
US medical experts on Wednesday voted unanimously against recommending approval of Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc.
235507
Merck next month will make its second try for approval to sell cholesterol drug Mevacor without a prescription. If the Food and Drug Administration approves, cholesterol drugs would
256773
The US Food and Drug Administration said on Friday that Senate testimony by a veteran FDA researcher regarding safety risks for five drugs does not reflect the views of the agency.
132632
The Food and Drug Administration is unlikely to sanction Boston Scientific Corp. after reviewing its handling of safety recalls of its new cardiac stent system, an agency official said yesterday.
25832
The American Heart Association defended the drug Vytorin, an expensive drug combination for cholesterol, which was shown last week to work no better than Zocor, a cheaper alternative.
112661
A U.S. advisory panel  urged the government on Thursday to reject Merck & Co Inc's   latest bid to sell the first cholesterol-lowering drug  without a prescription.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
223287
The panel said that while Americans could benefit from taking a Merck cholesterol-lowering drug, they should not begin such a regimen without a doctor's advice.
696865
Federal health advisers recommended against over-the-counter sales of a cholesterol drug, saying that patients need medical guidance in treating a condition that has no symptoms and may require drugs for life to stay healthy.
140672
WASHINGTON - The Food and Drug Administration silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes, the chairman of the Senate Finance Committee said Thursday...
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
687565
NEW YORK - A US Food and Drug Administration advisory panel rejected Procter &amp; Gamble&#39;s testosterone patch to treat female sexual dysfunction.